Company

Lavipharm SA

Headquarters: Paiania, Greece

Employees: 251

ASE: LAVI -2.32%

Market Cap

€145.4 Million

EUR as of July 1, 2024

US$156.1 Million

Market Cap History

Lavipharm SA market capitalization over time

Evolution of Lavipharm SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Lavipharm SA

Detailed Description

Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sales, wholesaling, and retailing of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; over the counter (OTC) drugs, such as antiseptics, and analgesics; gynecological products; and anti-lice treatment drugs. It also provides transdermal drug delivery systems (TDDS) related to pain management, hypertension, angina pectoris, Parkinson disease, asthma, female or male hormone replacement therapy, contraception, nausea, incontinence, etc. In addition, the company's product pipeline includes nicotine TDDS for smoking cessation; TDDS for hypertension; range of OTC products for common cold, oral hygiene, excessive excretion of shawl; food supplements; and anti-ageing products. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Lavipharm SA has the following listings and related stock indices.


Stock: ASE: LAVI wb_incandescent

Details

Headquarters:

Agias Marinas Street

PO Box 59

Paiania, 190 02

Greece

Phone: 30 210 66 91 000

Fax: 30 210 66 42 310